More than 105,000 diabetes patients in England could be eligible for a new technology, likened to an artificial pancreas, that promises to make type 1 diabetes a “thing of the past”.
The National Institute for Health and Care Excellence (Nice) has recommended the use of the “hybrid closed-loop system”, which helps patients manage blood sugar levels without the need to constantly monitor themselves, in order to control their condition.
